No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Cresco Labs Inc: MDA EN
Cresco Labs Inc: AUDITED ANNUAL FINANCIAL STATEMENTS EN
Cannabis Firm Cresco Labs Reports Mixed Q4, CEO Says Company Will 'Strategically Deploy Capital To Create Growth' In 2025
Press Release: Cresco Labs' Disciplined Strategy Drives Record Cash Flow in 2024 Financial Results
Cresco Labs to Operate Kentucky's Largest Medical Cannabis Cultivation License
Cresco Labs Inc. Price Target Cut to C$3.50/Share From C$4.25 by ATB Capital